Public health

How we can begin overcoming patients’ fears and misconceptions of cell and gene therapy

Expert pathologist Fred Plapp offers a summary of the virus causing COVID-19, its effects, and the pandemic’s evolving status

Could modulation of fibroblast growth factor 21 translate into a new treatment for non-alcoholic fatty liver disease?

We explore the work of researchers aiming to revolutionize the diagnosis of fibromyalgia and cholera using blood-based technologies.

How early telltales of tumors are frequently missed by both patients and clinicians

We don’t fully understand how probiotics affect cancer patient prognosis, so they should be approached with caution – at least for now.

How targeting subclinical populations with a rapid saliva test may aid in the quest to eradicate the disease.

As healthcare systems across the globe feel the strain of an increasing (and aging) population, we need someone – or rather something – to lend a help

A antibody discovery platform emerges to tackle the growing problem of Andes Hantavirus cardiopulmonary syndrome (AHCPS)

We talk to Humanity in Science Award winner Richard Jähnke about counterfeit drugs, and how the Minilab can help